The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    Biosensor could personalize cancer care

    Article obtained from BioPhotonics RSS Feed.

    Liquid biopsies have the potential to revolutionize cancer care for patients. Our team at the University of Iowa — which includes me, pharmaceutical sciences professor Aliasger Salem, and Dr. Pashtoon Kasi of the Department of Internal Medicine — is developing a silicon nanowire (SiNW) biosensor point-of-care platform to overcome the current limitations of detecting protein and circulating tumor DNA (ctDNA) biomarkers in liquid biopsies. While some factors are disease-specific (for example, shedding of DNA by tumor type), others are treatment related. Timing of the assay can drastically affect the agreement within these assays because the shedding of DNA goes down markedly once a person starts — and responds to —…

    Dec, 09 2019 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.